Inhibition of protein kinase Cβ protects against diabetes-induced impairment in arachidonic acid dilation of small coronary arteries

Journal of Pharmacology and Experimental Therapeutics

Volumn 319, Issue 1, 2006, Pages 199-207

  Zhou, Wei ^a   Wang, Xiao Li ^a   Lamping, Kathryn G ^b   Lee, Hon Chi ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; IBERIOTOXIN; MICONAZOLE; NITROPRUSSIDE SODIUM; PROTEIN KINASE C BETA; REACTIVE OXYGEN METABOLITE; RUBOXISTAURIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DIABETES MELLITUS; ENZYME INHIBITION; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR DISEASE;

ANIMALS; ARACHIDONIC ACID; CORONARY VESSELS; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES MELLITUS, EXPERIMENTAL; INDOLES; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MALEIMIDES; OXIDATIVE STRESS; OXYGENASES; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; SUPEROXIDE DISMUTASE; VASODILATION;

EID: 33749000621     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.106666     Document Type: Article

References (40)

1. Beckman JA, Creager MA, and Libby P (2002a) Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. J Am Med Assoc 287:2570-2581.
2. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, and Creager MA (2002b) Inhibition of protein kinase Cβ prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 90:107-111.
3. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature (Lond) 414:813-820.
4. Burnham MP, Bychkov R, Feletou M, Richards GR, Vanhoutte PM, Weston AH, and Edwards G (2002) Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol 135:1133-1143.
5. Cameron NE and Cotter MA (2002) Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism. Diabetes Metab Res Rev 18:315-323.
6. Chrissobolis S and Sobey CG (2002) Inhibitory effects of protein kinase C on inwardly rectifying K+- and ATP-sensitive K+ channel-mediated responses of the basilar artery. Stroke 33:1692-1697.
7. Ciechanowski K, Kedzierska K, Golembiewska E, Safranow K, Bober J, Domanski L, Rozanski J, and Myslak M (2005) Impaired synthesis is not the reason for decreased activity of extracellular superoxide dismutase in patients with diabetes. Arch Med Res 36:148-153.
8. Cooper ME, Bonnet F, Oldfield M, and Jandeleit-Dahm K (2001) Mechanisms of diabetic vasculopathy: an overview. Am J Hypertension 14:475-486.
9. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, and Vanhoutte PM (2000) Endothelial dysfunction in diabetes. Br J Pharmacol 130:963-974.
10. Egan BM, Green EL, and Goodfriend TL (2001) Insulin resistance and cardiovascular disease. Am J Hypertension 14:116S-125S.
11. Erdos B, Simandle SA, Snipes JA, Miller AW, and Busija DW (2004) Potassium channel dysfunction in cerebral arteries of insulin-resistant rats is mediated by reactive oxygen species. Stroke 35:964-969.
12. Foegh ML and Pamwell PW (2002) The eicosanoids: prostaglandins, thromboxanes, leukotriences, and related compounds, in Basic and Clinical Pharmacology (Katzung BG ed), McGraw-Hill Companies, New York.
13. Fukai T, Folz RJ, Landmesser U, and Harrison DG (2002) Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55:239-249.
14. Geiss LS, Herman WH, Smith PJ, and Group NDD (1995) Diabetes in America, pp 233-257. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
15. Gutterman DD (2002) Vascular dysfunction in hypertriglycemia. Is protein kinase C the culprit? Circ Res 90:5-7.
16. ATP channels by inhibiting steady-state protein kinase A activity and activating protein kinase Cε. J Physiol (Lond) 530:193-205.
17. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, et al. (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88:E14-E22.
18. Iida S, Chu Y, Francis J, Weiss RM, Gunnett CA, Faraci FM, and Heistad DD (2005) Gene transfer of extracellular superoxide dismutase improves endothelial function in rats with heart failure. Am J Physiol 289:H525-H532.
19. Inoguchi T, Battan R, Handler E, Sportsman J, Heath W, and King GL (1992) Preferential elevation of protein kinase C isoforms β II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89:11059-11063.
20. Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, et al. (2003) Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 14:S227-S232.
21. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Ballas LM, Heath WF, et al. (1996) Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science (Wash DC) 272:728-731.
22. Li H, Gutterman DD, Rusch NJ, Bubolz A, and Liu Y (2004) Nitration and functional loss of voltage-gated K+ channels in rat coronary microvessels exposed to high glucose. Diabetes 53:2436-2442.
23. Lin HL, Zhang H, Waskell L, and Hollenberg PF (2005) The highly conserved Glu149 and Tyr190 residues contribute to peroxynitrite-mediated nitrotyrosine formation and the catalytic activity of cytochrome P450 2B1. Chem Res Toxicol 18:1203-1210.
24. Liu Y, Terata K, Chai Q, Li H, Kleinman LH, and Gutterman DD (2002) Peroxynitrite inhibits Ca2+-activated K+ channel activity in smooth muscle of human coronary arterioles. Circ Res 91:1070-1076.
25. Lu T, Wang XL, He T, Zhou W, Kaduce TL, Katusic ZS, Spector AA, and Lee H (2005) Impaired arachidonic acid-mediated activation of large-conductance Ca2+-activated K+ channels in coronary arterial smooth muscle cells in Zucker Diabetic Fatty rats. Diabetes 54:2155-2163.
26. Miller AW, Katakam PV, Lee H, Tulbert CD, Busija DW, and Weintraub NL (2003) Arachidonic acid-induced vasodilation of rat small mesenteric arteries is lipoxygenase-dependent. J Pharmacol Exp Ther 304:139-144.
27. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, and Davidson BL (1998) Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82:1298-1305.
28. Miura H and Gutterman DD (1998) Human coronary arteriolar dilation to arachidonic acid depends on cytochrome P-450 monooxygenase and Ca2+-activated K+ channels. Circ Res 83:501-507.
29. Munzel T, Afanas'ev IB, Kleschyov AL, and Harrison DG (2002) Detection of superoxide in vascular tissue. Arterioscl Thromb Vasc Biol 22:1761-1768.
30. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature (Lond) 404:787-790.
31. Nonaka A, Kiryu J, Tsujikawa A, Yamashiro K, Miyamoto K, Nishiwaki H, Honda Y, and Ogura Y (2000) PKC-beta inhibitor (LY333531) attenuates leukocyte entrapment in retinal microcirculation of diabetic rats. Investig Ophthalmol Vis Sci 41:2702-2706.
32. Shipston MJ and Armstrong DL (1996) Activation of protein kinase C inhibits calcium-activated potassium channels in rat pituitary tumour cells. J Physiol (Lond) 493:665-672.
33. Tamai M, Furuta H, Kawashima H, Doi A, Hamanishi T, Shimomura H, Sakagashira S, Nishi M, Sasaki H, Sanke T, et al. (2006) Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes. Diabetes Res Clin Pract 71:140-145.
34. Tang XD, Garcia ML, Heinemann SH, and Hoshi T (2004) Reactive oxygen species impair Slo1 BK channel function by altering cysteine-mediated calcium sensing. Nat Struct Mol Biol 11:171-178.
35. Tesfamariam B, Brown ML, and Cohen RA (1991) Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Investig 87:1643-1648.
36. Tuttle KR and Anderson PW (2003) A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition. Am J Kidney Dis 42:456-465.
37. Way KJ, Katai N, and King GL (2001) Protein kinase C and the development of diabetic vascular complications. Diabetic Med 18:945-959.
38. Wong LC and Langille BL (1996) Developmental remodeling of the internal elastic lamina of rabbit arteries: effect of blood flow. Circ Res 78:799-805.
39. Zhou W, Wang XL, Kaduce TL, Spector AA, and Lee H (2005) Impaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty rats. Am J Physiol 288:H2210-H2218.
40. Zou MH, Shi C, and Cohen RA (2002) High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51:198-203.